Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Trending
Antibody Data
Oct 26, 2026
Does Antibody Development Have a Data Problem?
Drug Pricing
Mar 12, 2019
Balancing Ethical and Fiduciary Responsibilities in Drug Pricing
New Technology
Sep 30, 2026
What are the key bottlenecks preventing rapid adoption of novel technologies?
See everything
Press Releases
Spray Drying
Sep 29, 2026
Serán Bioscience Strengthens Spray Dry Capabilities with Growth Investment From Biospring Partners
AMT Designation
Sep 23, 2026
AustinPx’s KinetiSol™ Technology Receives FDA Advanced Manufacturing Technology Designation
More Press Releases
SmartScale
Oct 21, 2026
Phase-Appropriate CMC Requires a New Phase-Appropriate Manufacturing Model
GBI Biomanufacturing's Jesse McCool explains how clearer FDA flexibility, stable-pool strategies, and right-sized GMP manufacturing can reshape first-in-human biologics development around the needs of the clinical program.
Related
CMC and Investment
Jan 15, 2026
Where Capital Meets CMC: The Emerging Role of CDMOs in Investor Risk Assessment
In a capital-disciplined biopharma market shaped by regulatory transparency, manufacturability has emerged as an early, visible signal of execution risk, reshaping investor diligence and elevating CDMOs from service providers to technical validators of asset credibility.
Conjugation
May 20, 2026
Why ADC Conjugation Strategy Is Now a CMC Decision
Site-specific conjugation is reshaping antibody–drug conjugate development by making payload attachment a CMC and manufacturing strategy, not simply a chemistry choice.
Topics
Pharma 4.0
Nov 4, 2026
The Business Case for Pharma 4.0: Measuring the Return on Digital Investment
Distributor
Oct 26, 2026
Beyond Logistics: How Modern Chemical Distributors Accelerate Pharmaceutical Development
CCS and CMC
Sep 14, 2026
Packaging Returns to the Center of CMC Strategy
See all articles
Nice Insight
Sterile Fill Finish Report
ADC Report
State of the Industry Report
see all in Nice Insight Reports
Mammalian Cell Culture, Biologics: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Antibody–Drug Conjugate, ADC: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Sterile Fill Finish: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Nice Insight's State of the Industry 2026: Inside the CDMO Landscape
Open access
Active Pharmaceutical Ingredients, API: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Oral Solid Dose, OSD: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Microbial Fermentation, Biologics: Market Insight, CDMO Pricing and Benchmarking
Open access
Gene Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Cell Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Mammalian Cell Culture, Biologics: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Antibody–Drug Conjugate, ADC: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Sterile Fill Finish: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Nice Insight's State of the Industry 2026: Inside the CDMO Landscape
Open access
Active Pharmaceutical Ingredients, API: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Oral Solid Dose, OSD: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Microbial Fermentation, Biologics: Market Insight, CDMO Pricing and Benchmarking
Open access
Gene Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Cell Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking
Open access
Content Hub
Articles
Expert Interviews
Roundtables
Videos
ADCs
May 21, 2026
Re-Engineering ADCs for Autoimmune and Inflammatory Disease
Expert Insights
Road To Experience
Press Releases
Videos
ADC Engineering
May 4, 2026
Engineering Antibodies for Precision Payload Delivery
Conjugation
May 20, 2026
Why ADC Conjugation Strategy Is Now a CMC Decision
ADC Linkers
May 8, 2026
Linker Chemistry as the Hidden Determinant of ADC Success
Expert Insights
Road To Experience
Press Releases
Videos
Discovery
API – Small Molecules
Biologics
Cell and Gene Therapy
see all in Discovery
Parasitic Diseases
Nov 6, 2026
Therapeutics and Vaccines for Parasitic Infections: A Quick Overview and Rececnt Advances
Metabolic Disease
Nov 5, 2026
Precision Medicine in Metabolic Disease: Can We Predict Who Responds to Which Therapy?
Sustainability
Oct 30, 2026
How is sustainability shifting from a reporting exercise to a design constraint in manufacturing and development?
Liquids & Semisolids
Jul 22, 2026
What Makes a Great Liquid Oral Dose CDMO?
Small Molecules
Drug Discovery and Development
Formulation
Manufacturing
see all in Small Molecule
API Oversight
Sep 28, 2026
Can Regulatory Reliance Make Global API Oversight More Efficient?
Pathfinder
Oct 2, 2026
Spray-Dried Dispersions vs. Nanocrystals: Which Is Better for Solubility Enhancement?
Pathfinder
Sep 25, 2026
Micronization vs. Nanomilling vs. Amorphous Solid Dispersions: Which Is Better for Poorly Soluble Drugs?
Heme-Onc
Sep 24, 2026
The Next Generation of Targeted Therapies in Hematologic Malignancies
ASDs
Oct 20, 2026
The Evolving Science of Amorphous Solid Dispersions
Biocatalysis
Sep 28, 2026
When Does Biocatalysis Create the Better Manufacturing Process?
Distributor
Oct 26, 2026
Beyond Logistics: How Modern Chemical Distributors Accelerate Pharmaceutical Development
Flow Chemistry
Oct 20, 2026
When Flow Chemistry Solves the Manufacturing Problem
Multi-Modality CDMO
Sep 24, 2026
The Rise of the Multi-Modality CDMO: Why Clients Need More Than Capacity
API Oversight
Sep 28, 2026
Can Regulatory Reliance Make Global API Oversight More Efficient?
Pathfinder
Oct 2, 2026
Spray-Dried Dispersions vs. Nanocrystals: Which Is Better for Solubility Enhancement?
Pathfinder
Sep 25, 2026
Micronization vs. Nanomilling vs. Amorphous Solid Dispersions: Which Is Better for Poorly Soluble Drugs?
Heme-Onc
Sep 24, 2026
The Next Generation of Targeted Therapies in Hematologic Malignancies
ASDs
Oct 20, 2026
The Evolving Science of Amorphous Solid Dispersions
Biocatalysis
Sep 28, 2026
When Does Biocatalysis Create the Better Manufacturing Process?
Distributor
Oct 26, 2026
Beyond Logistics: How Modern Chemical Distributors Accelerate Pharmaceutical Development
Flow Chemistry
Oct 20, 2026
When Flow Chemistry Solves the Manufacturing Problem
Multi-Modality CDMO
Sep 24, 2026
The Rise of the Multi-Modality CDMO: Why Clients Need More Than Capacity
Sponsored Content
Drug Discovery and Development
Formulation
Manufacturing
Advanced Therapies
Oncology
Jul 23, 2026
Harnessing Macrophage Biology to Overcome Tumor Immune Evasion
Allogeneic CAR-T
Sep 18, 2026
Can Allogeneic Cell Therapy Solve the CAR-T Access Problem?
Partner Selection
Aug 28, 2026
How are organizations balancing cost with regulatory, supply chain, and reputational risk when selecting partners or sites?
Site Network
Aug 11, 2026
How Regional Sites in a Global Site Network Combine Local Insight with Global Scale
Technologies
Drug Discovery and Development
Manufacturing
Artificial Intelligence
see all in Technologies
New Technology
Sep 30, 2026
What are the key bottlenecks preventing rapid adoption of novel technologies?
Bioprocessing
Oct 9, 2026
Bioprocessing and Capacity Trends: Growth Despite Continued Uncertainty
AAV Analytics
Oct 13, 2026
Advancing AAV Gene Therapies Through Analytical Innovation
Organ-on-a-Chip
Oct 15, 2026
Why Multi-Organ Chips Are a Manufacturing and Standardization Challenge
Genome Engineering
Jun 29, 2026
Aiming for More than Single-Base Corrections: The Technologies Opening the Genome to Therapeutic Cargo
Orthogonal Methods
Oct 22, 2026
Orthogonal Analytics: How Much Characterization Is Enough?
MPS
Aug 31, 2026
What Will It Take for Organ-on-Chip Data to Replace Animal Studies?
Data-Driven Mfg
Oct 21, 2026
Data-Driven Manufacturing and Digital Twins Across the Biologics Network
AMT Designation
Sep 23, 2026
AustinPx’s KinetiSol™ Technology Receives FDA Advanced Manufacturing Technology Designation
New Technology
Sep 30, 2026
What are the key bottlenecks preventing rapid adoption of novel technologies?
Bioprocessing
Oct 9, 2026
Bioprocessing and Capacity Trends: Growth Despite Continued Uncertainty
AAV Analytics
Oct 13, 2026
Advancing AAV Gene Therapies Through Analytical Innovation
Organ-on-a-Chip
Oct 15, 2026
Why Multi-Organ Chips Are a Manufacturing and Standardization Challenge
Genome Engineering
Jun 29, 2026
Aiming for More than Single-Base Corrections: The Technologies Opening the Genome to Therapeutic Cargo
Orthogonal Methods
Oct 22, 2026
Orthogonal Analytics: How Much Characterization Is Enough?
MPS
Aug 31, 2026
What Will It Take for Organ-on-Chip Data to Replace Animal Studies?
Data-Driven Mfg
Oct 21, 2026
Data-Driven Manufacturing and Digital Twins Across the Biologics Network
AMT Designation
Sep 23, 2026
AustinPx’s KinetiSol™ Technology Receives FDA Advanced Manufacturing Technology Designation
Biologics
Drug Discovery and Development
Formulation
Manufacturing
see all in Biologics
Fed-Batch
Nov 5, 2026
Advancing S-Tensify™ Through Cell-Line-Specific Process Optimization
Analytical Strategy
Nov 5, 2026
Analytical Strategy as a Competitive Advantage in Biologics Development
Antibody Data
Oct 26, 2026
Does Antibody Development Have a Data Problem?
Pathfinder
Jul 10, 2026
Offshoring vs. Reshoring vs. Half-Shoring: Which Manufacturing Strategy Is Best for Pharma?
Advanced Therapies
Drug Discovery and Development
Formulation
Manufacturing
see all in Advanced Therapies
Antibody Data
Oct 26, 2026
Does Antibody Development Have a Data Problem?
Heme-Onc
Sep 28, 2026
Therapeutic and Diagnostic Advances Benefiting Patients with Hematologic Malignancies
AAV Analytics
Oct 13, 2026
Advancing AAV Gene Therapies Through Analytical Innovation
Nonviral Delivery
Oct 5, 2026
Can Nonviral Delivery Change the Economics of Gene Therapy?
LNP Analytics
Oct 6, 2026
Beyond Particle Size: Building a Complete Analytical Strategy for LNPs
ADCs
Oct 8, 2026
How Lessons from Breast Cancer Are Shaping ADC Development Across Solid Tumors
Viral Vectors
Oct 1, 2026
Gene Therapy Manufacturing After the Capacity Boom
Cell Therapy
Oct 26, 2026
Overcoming Formulation and Fill/Finish Challenges for Cell Therapies
CGT Release
Oct 12, 2026
Release Testing as a Cell and Gene Therapy Manufacturing Bottleneck
Antibody Data
Oct 26, 2026
Does Antibody Development Have a Data Problem?
Heme-Onc
Sep 28, 2026
Therapeutic and Diagnostic Advances Benefiting Patients with Hematologic Malignancies
AAV Analytics
Oct 13, 2026
Advancing AAV Gene Therapies Through Analytical Innovation
Nonviral Delivery
Oct 5, 2026
Can Nonviral Delivery Change the Economics of Gene Therapy?
LNP Analytics
Oct 6, 2026
Beyond Particle Size: Building a Complete Analytical Strategy for LNPs
ADCs
Oct 8, 2026
How Lessons from Breast Cancer Are Shaping ADC Development Across Solid Tumors
Viral Vectors
Oct 1, 2026
Gene Therapy Manufacturing After the Capacity Boom
Cell Therapy
Oct 26, 2026
Overcoming Formulation and Fill/Finish Challenges for Cell Therapies
CGT Release
Oct 12, 2026
Release Testing as a Cell and Gene Therapy Manufacturing Bottleneck
Manufacturing
Small Molecules
Biologics
Cell and Gene Therapy
See all in Manufacturing
Protein Misfolding
Jun 15, 2026
Protein Misfolding as a Therapeutic Axis in Neurodegenerative Disease
Fed-Batch
Nov 5, 2026
Advancing S-Tensify™ Through Cell-Line-Specific Process Optimization
Pharma 4.0
Nov 4, 2026
The Business Case for Pharma 4.0: Measuring the Return on Digital Investment
Digitalization
Nov 3, 2026
The Digital Divide Between Drug Substance and Drug Product Manufacturing
Supply Chain
Cell and Gene Therapy
Clinical Supply
Manufacturing
see all in Supply Chain
Partner Selection
Aug 28, 2026
How are organizations balancing cost with regulatory, supply chain, and reputational risk when selecting partners or sites?
Preparedness
Aug 20, 2026
Preparing Manufacturing Networks for the Next Pandemic
ATMP Supply Chain
Aug 13, 2026
Maintaining Resilient Supply Chains for Advanced Therapies
Biologics
Sep 1, 2026
Commercial Thinking Begins in Clinical Phases
Distributor
Oct 26, 2026
Beyond Logistics: How Modern Chemical Distributors Accelerate Pharmaceutical Development
Biosimilars
Sep 15, 2026
The Global Division of Labor Behind the Coming Oncology Biosimilar Wave
Drug Shortage
Sep 22, 2026
What It Actually Takes to Engineer a Drug Supply Chain Out of Shortage
Thermostable Vaccine
Aug 10, 2026
Thermostable Vaccines and the Future of Global Distribution
Supply Chain
Aug 19, 2026
Supply Chain Resilience in 2026: Any Progress?
Partner Selection
Aug 28, 2026
How are organizations balancing cost with regulatory, supply chain, and reputational risk when selecting partners or sites?
Preparedness
Aug 20, 2026
Preparing Manufacturing Networks for the Next Pandemic
ATMP Supply Chain
Aug 13, 2026
Maintaining Resilient Supply Chains for Advanced Therapies
Biologics
Sep 1, 2026
Commercial Thinking Begins in Clinical Phases
Distributor
Oct 26, 2026
Beyond Logistics: How Modern Chemical Distributors Accelerate Pharmaceutical Development
Biosimilars
Sep 15, 2026
The Global Division of Labor Behind the Coming Oncology Biosimilar Wave
Drug Shortage
Sep 22, 2026
What It Actually Takes to Engineer a Drug Supply Chain Out of Shortage
Thermostable Vaccine
Aug 10, 2026
Thermostable Vaccines and the Future of Global Distribution
Supply Chain
Aug 19, 2026
Supply Chain Resilience in 2026: Any Progress?
Finance
M&A
CDMO
Strategic Partnership
see all in Financing
Pharma 4.0
Nov 4, 2026
The Business Case for Pharma 4.0: Measuring the Return on Digital Investment
OpenAI Funding
Oct 19, 2026
OpenAI Foundation: The Why and How of Its Life Science Research Funding Agenda
Bioprocessing
Oct 9, 2026
Bioprocessing and Capacity Trends: Growth Despite Continued Uncertainty
Protein Misfolding
Jun 15, 2026
Protein Misfolding as a Therapeutic Axis in Neurodegenerative Disease
Expert Insights
Drug Discovery and Development
CDMO
CRO
see all in Expert Insights
CDMO
Nov 13, 2025
Efficiency by Design: Meeting the Evolving Challenges of a Maturing Global Biologics Market
CDMO Excellence
Dec 2, 2025
Delivering CDMO Excellence, Quality, and Value through Dedication
Clinical Diversity
Jun 12, 2025
Redefining Access: Embedding Diversity into the Clinical Research Ecosystem
Antibodies
Aug 22, 2025
Co-Founders of Biotech Avidicure Talk New Antibody Modality, Starting from Scratch, and $50M Launch
Oncology
Jul 23, 2026
Harnessing Macrophage Biology to Overcome Tumor Immune Evasion
Clinical Diversity
Jun 12, 2025
Staying the Course: Sustaining Equity in Clinical Trials Amid Headwinds
Ovarian Cancer
Apr 21, 2026
Oncolytic Viruses at a Turning Point: Advancing Olvi-Vec for Advanced Ovarian Cancer
Masked Antibody
Aug 14, 2026
Expanding the Oncology Therapeutic Window Through Masked Antibody Technology
APM
Oct 28, 2025
Raising the Bar in Analytical Excellence: Samsung Biologics’ Approach to Assay Performance Monitoring
CDMO
Nov 13, 2025
Efficiency by Design: Meeting the Evolving Challenges of a Maturing Global Biologics Market
CDMO Excellence
Dec 2, 2025
Delivering CDMO Excellence, Quality, and Value through Dedication
Clinical Diversity
Jun 12, 2025
Redefining Access: Embedding Diversity into the Clinical Research Ecosystem
Antibodies
Aug 22, 2025
Co-Founders of Biotech Avidicure Talk New Antibody Modality, Starting from Scratch, and $50M Launch
Oncology
Jul 23, 2026
Harnessing Macrophage Biology to Overcome Tumor Immune Evasion
Clinical Diversity
Jun 12, 2025
Staying the Course: Sustaining Equity in Clinical Trials Amid Headwinds
Ovarian Cancer
Apr 21, 2026
Oncolytic Viruses at a Turning Point: Advancing Olvi-Vec for Advanced Ovarian Cancer
Masked Antibody
Aug 14, 2026
Expanding the Oncology Therapeutic Window Through Masked Antibody Technology
APM
Oct 28, 2025
Raising the Bar in Analytical Excellence: Samsung Biologics’ Approach to Assay Performance Monitoring
Road To Series
STAGING